TG테라퓨틱스사 (TGTX)

May 06, 2025

TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 06, 2025

May 06, 2025

TG Therapeutics First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

May 06, 2025

May 06, 2025

TG Therapeutics Inc (TGTX) Q1 2025 Earnings Call Highlights: Str - GuruFocus

May 06, 2025

May 06, 2025

Jefferies maintains Buy on TGTX stock with $46 target By Investing.com - Investing.com Nigeria

May 06, 2025

May 06, 2025

TG Therapeutics Inc (TGTX) Q1 2025 Earnings Call Highlights: Strong BRIUMVI Sales and Increased ... - Yahoo Finance

May 06, 2025

May 06, 2025

TG Therapeutics Boosts Retail Sentiment With Q1 Revenue Beat Even As Stock Tumbles On Profit Miss, Conservative Outlook - MSN

May 06, 2025

May 06, 2025

TG Therapeutics Boosts Retail Sentiment With Q1 Revenue Beat Even As Stock Tumbles On Profit Miss, Conservative Outlook By Stocktwits - Investing.com India

May 06, 2025

May 05, 2025

TG Therapeutics: Q1 Earnings Snapshot - MySA

May 05, 2025

May 05, 2025

TG Therapeutics raises 2025 guidance to $560M, driven by BRIUMVI adoption - MSN

May 05, 2025

May 05, 2025

TG Therapeutics Falls Short On Earnings, But Briumvi Sales Steal the Show - Benzinga

May 05, 2025

May 05, 2025

Why TG Therapeutics Stock Was Tumbling Today - AOL.com

May 05, 2025

May 05, 2025

TGTX Stock Dips Despite Surging Revenue and Profitability - GuruFocus

May 05, 2025

May 05, 2025

Jefferies maintains Buy on TGTX stock with $46 target - Investing.com

May 05, 2025

May 05, 2025

TG Therapeutics: Share Price Slip On Q1 Earnings Unsurprising Given Challenges (TGTX) - Seeking Alpha

May 05, 2025

May 05, 2025

TG Therapeutics (TGTX) Stock Falls After Earnings Miss Despite Raised Guidance - GuruFocus

May 05, 2025

May 05, 2025

TG Therapeutics stock sinks on profit miss (TGTX:NASDAQ) - Seeking Alpha

May 05, 2025

May 05, 2025

Strong Q1 Performance for TG Therapeutics (TGTX) with BRIUMVI Growth - GuruFocus

May 05, 2025

May 05, 2025

Earnings call transcript: TG Therapeutics misses Q1 2025 EPS forecast, shares dip - Investing.com

May 05, 2025

May 05, 2025

TG Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 05, 2025

May 05, 2025

TG Therapeutics Stock Tumbles After Q1 Earnings Fall Short Of Wall Street Estimates: But Retail’s Optimistic - MSN

May 05, 2025

May 05, 2025

TG Therapeutics (TGTX) Lags Q1 Earnings Estimates - Yahoo Finance

May 05, 2025

May 05, 2025

TG Therapeutics (TGTX) Misses Q1 EPS Estimates, Raises 2025 Revenue Projections - GuruFocus

May 05, 2025

May 05, 2025

TG Therapeutics Inc (TGTX) Reports Q1 2025 Revenue of $119.7 Million, Surpassing Estimates - GuruFocus

May 05, 2025

May 05, 2025

TG Therapeutics' Q1 Swings to Net Income, Revenue Rises; Full-Year 2025 BRIUMVI Revenue Guidance Updated - marketscreener.com

May 05, 2025

May 05, 2025

TG Therapeutics Reports First Quarter 2025 Financial Results - TradingView

May 05, 2025

May 05, 2025

TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance | TGTX Stock News - GuruFocus

May 05, 2025

May 05, 2025

TG Therapeutics Q1 revenue beats estimates, stock edges higher By Investing.com - Investing.com Canada

May 05, 2025

May 05, 2025

TG Therapeutics Q1 revenue beats estimates, stock edges higher - Investing.com

May 05, 2025

May 05, 2025

TGTX Surpasses Revenue Expectations with Strong Q1 Performance | TGTX Stock News - GuruFocus

May 05, 2025

May 05, 2025

Earnings Flash (TGTX) TG Therapeutics Posts Q1 EPS $0.03, vs. FactSet Est of $0.17 - marketscreener.com

May 05, 2025

May 05, 2025

Earnings Flash (TGTX) TG Therapeutics Reports Q1 Revenue $120.9M, vs. FactSet Est of $117.9M - marketscreener.com

May 05, 2025

May 05, 2025

TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance - GlobeNewswire

May 05, 2025

May 05, 2025

TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance - GlobeNewswire Inc.

May 05, 2025

May 05, 2025

TG Therapeutics Earnings Loom With Stock (NASDAQ: TGTX) Outperforming Market - AskTraders.com

May 05, 2025

May 04, 2025

When (TGTX) Moves Investors should Listen - news.stocktradersdaily.com

May 04, 2025

May 03, 2025

TG Therapeutics (TGTX) Schedules Q1 2025 Earnings Call - GuruFocus

May 03, 2025

May 02, 2025

TG Therapeutics (TGTX) Poised for Major Earnings Growth in Q1 - GuruFocus

May 02, 2025

Apr 30, 2025

TG Therapeutics stock soars to 52-week high of $45.28 By Investing.com - Investing.com India

Apr 30, 2025

Apr 30, 2025

TG Therapeutics stock soars to 52-week high of $45.28 - Investing.com

Apr 30, 2025

Apr 30, 2025

TG Therapeutics (TGTX) to Report Q1 Results: Wall Street Expects Earnings Growth - Yahoo Finance

Apr 30, 2025

Apr 30, 2025

TG Therapeutics to Host Conference Call on First Quarter 2025 Fi - GuruFocus

Apr 30, 2025

Apr 30, 2025

TG Therapeutics to Host Conference Call on May 5, 2025, to Discuss Q1 Financial Results and 2025 Outlook - Nasdaq

Apr 30, 2025

Apr 30, 2025

TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update - GlobeNewswire

Apr 30, 2025

Apr 29, 2025

Investor Network: TG Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire

Apr 29, 2025

Apr 28, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 28, 2025

Apr 28, 2025

TG Therapeutics (NasdaqCM:TGTX) Sees Profitable Turn With Strong Quarterly Earnings - Yahoo Finance

Apr 28, 2025

Apr 23, 2025

TG Therapeutics: Considering If The Promise Of Accelerated Revenue Growth Is Enough - Seeking Alpha

Apr 23, 2025

Apr 22, 2025

2 Reasons to Sell ESTC and 1 Stock to Buy Instead - The Globe and Mail

Apr 22, 2025

Apr 19, 2025

Where are the Opportunities in (TGTX) - news.stocktradersdaily.com

Apr 19, 2025

Apr 17, 2025

Exploring US High Growth Tech Stocks - simplywall.st

Apr 17, 2025

Apr 16, 2025

TG Therapeutics: Progress In MS Tempered By High Expectations (NASDAQ:TGTX) - Seeking Alpha

Apr 16, 2025